Pregabalin and topiramate regulate behavioural and brain gene transcription changes induced by spontaneous cannabinoid withdrawal in mice

Altered architecture and functional consequences of the mesolimbic dopamine system in cannabis dependence

(2010) Saturnino Spiga et al.   ADDICTION BIOLOGY

Anxiety-like effects of SR141716-precipitated delta9-tetrahydrocannabinol withdrawal in mice in the elevated plus-maze

(2010) Peng Huang et al.   NEUROSCIENCE LETTERS

Pregabalin in the discontinuation of long-term benzodiazepine use: a case-series

(2009) Panagiotis Oulis et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Modulation of Impulsivity by Topiramate

(2009) Gabriel Rubio et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

The cannabinoid CB1 receptor is involved in the anxiolytic, sedative and amnesic actions of benzodiazepines

(2009) María S García-Gutiérrez et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial

(2009) G. Martinotti et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Hyperlocomotion and paw tremors are two highly quantifiable signs of SR141716-precipitated withdrawal from delta9-tetrahydrocannabinol in C57BL/6 mice

(2009) Peng Huang et al.   NEUROSCIENCE LETTERS

Comparing topiramate with naltrexone in the treatment of alcohol dependence*

(2008) Danilo Antonio Baltieri et al.   ADDICTION

Efficacy and safety of pregabalin in alcohol dependence

(2008) Giovanni Martinotti et al.   ADVANCES IN THERAPY

Pharmacotherapy and psychotherapy in cannabis withdrawal and dependence

(2008) Amine Benyamina et al.   Expert Review of Neurotherapeutics

Craving decrease with topiramate in outpatient treatment for cocaine dependence: an open label trial

(2008) Alessandra Diehl Reis et al.   REVISTA BRASILEIRA DE PSIQUIATRIA